Platinum Investment Management LTD Mersana Therapeutics, Inc. Transaction History

Platinum Investment Management LTD

  • $2.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$4.63 - $8.0 $949,997 - $1.64 Million
-205,183 Reduced 41.41%
290,298 $1.96 Million
Q4 2021

Feb 11, 2022
BUY
$5.48 - $9.86 $2.11 Million - $3.79 Million
384,575 Added 346.76%
495,481 $3.08 Million
Q2 2020

Aug 06, 2020
BUY
$5.24 - $23.4 $581,147 - $2.6 Million
110,906 New
110,906 $2.6 Million

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $194M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email